---
schema_version: "secwatch.filing_event.v1"
accession: "0001434647-25-000018"
form_type: "8-K"
ticker: "ZVRA"
cik: "0001434647"
company_name: "ZEVRA THERAPEUTICS, INC."
filed_at: "2025-12-17T23:59:59+00:00"
generated_at: "2026-05-16T12:54:20.103905+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Zevra appoints Timothy Sangiovanni as interim CFO effective Jan 1, 2026

## Summary
- Timothy Sangiovanni named interim principal financial officer, effective January 1, 2026.
- Sangiovanni currently serves as SVP Finance and Corporate Controller; joined company in 2015.
- No change in compensation arrangements in connection with the appointment.
- No information provided on predecessor's departure or timing of permanent CFO search.

## SEC filing metadata
- accession: 0001434647-25-000018
- form_type: 8-K
- ticker: ZVRA
- cik: 0001434647
- company_name: ZEVRA THERAPEUTICS, INC.
- filed_at: 2025-12-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434647/000143464725000018/0001434647-25-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434647/000143464725000018/zvra-20251211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001434647-25-000018
- JSON: https://secwatch.observer/filing/0001434647-25-000018.json
- Plain text: https://secwatch.observer/filing/0001434647-25-000018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.